Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial

Jonathan W. Cunningham; Brian L. Claggett; Muthiah Vaduganathan; Akshay S. Desai; Pardeep S. Jhund; Carolyn S.P. Lam; Michele Senni; Sanjiv Shah; Adriaan Voors; Faiez Zannad; Bertram Pitt; Flaviana Amarante; James Lay-Flurrie; Katja Rohwedder; Laura Goea; Mario Berger; John J.V. McMurray; Scott D. Solomon

Journal ArticleOPEN ACCESS

Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial

European Journal of Heart Failure (2025) 27(8) 1487-1491

DOI: 10.1002/ejhf.3694

7Citations

12Readers

Cite

CITATION STYLE

APA

Cunningham, J. W., Claggett, B. L., Vaduganathan, M., Desai, A. S., Jhund, P. S., Lam, C. S. P., … Solomon, S. D. (2025). Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial. European Journal of Heart Failure, 27(8), 1487–1491. https://doi.org/10.1002/ejhf.3694

Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial

Cite

Register to see more suggestions